Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies

被引:41
作者
Lensen, JFM
Rops, ALWMM
Wijnhoven, TJM
Hafmans, T
Feitz, WFJ
Osterwijk, E
Banas, B
Bindels, RJM
van den Heuvel, LPWJ
van der Vlag, J
Berden, JHM
van Kuppevelt, TH
机构
[1] Univ Nijmegen, Radboud Med Ctr, Dept Biochem 194, NCMLS, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Radboud Med Ctr, NCMLS, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Radboud Med Ctr, NCMLS, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Radboud Med Ctr, NCMLS, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands
[5] Univ Nijmegen, Radboud Med Ctr, NCMLS, Dept Pediat Urol, NL-6500 HB Nijmegen, Netherlands
[6] Univ Nijmegen, Radboud Med Ctr, NCMLS, Dept Physiol, NL-6500 HB Nijmegen, Netherlands
[7] Univ Regensburg, Dept Internal Med 2, D-8400 Regensburg, Germany
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 05期
关键词
D O I
10.1681/ASN.2004050413
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Glycosaminoglycans (GAG) play an important role in renal homeostasis. They are strongly negatively charged polysaccharides that bind and modulate a myriad of proteins, including growth factors, cytokines, and enzymes. With the aid of specific phage display-derived antibodies, the distribution of heparan sulfate (HS) and chondroitin sulfate (CS) domains in the normal human kidney was studied. HS domains were specifically located in basement membranes and/or surfaces of renal cells and displayed a characteristic distribution over the nephron. A characteristic location in specific parts of the tubular system was also observed. CS showed mainly an interstitial location. Immunoelectron microscopy indicated specific ultrastructural location of domains. Only partial overlap with any of seven different proteoglycan core proteins was observed. Two HS domains, one highly sulfated (defined by antibody HS4C3) and one low sulfated (defined by antibody RB4Ea12), were studied for their cell biologic relevance with respect to the proliferative effect of FGF-2 on human mesangial cells in vitro. Fibroblast growth factor 2 (FGF-2) binding was HS dependent. Addition of purified HS4C3 antibody but not of the RB4Ea12 antibody counteracted the binding and the proliferative effect of FGF-2, indicating that the HS4C3 domain is involved in FGF-2 handling by mesangial cells. In conclusion, specific GAG domains are differentially distributed in the normal human kidney and are likely involved in binding of effector molecules such as FGF-2. The availability of tools to identify and study relevant GAG structures allows the development of glycomimetica to halt, for instance, mesangial proliferation and matrix production as seen in diabetic nephropathy.
引用
收藏
页码:1279 / 1288
页数:10
相关论文
共 50 条
[1]
Banas B, 1999, J AM SOC NEPHROL, V10, P2314
[2]
Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[3]
Clayton A, 2001, KIDNEY INT, V59, P2084, DOI 10.1046/j.1523-1755.2001.00723.x
[4]
Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications [J].
Conde-Knape, K .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2001, 17 (06) :412-421
[5]
Conrad H.E., 1998, HEPARIN BINDING PROT
[6]
Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies [J].
Dennissen, MABA ;
Jenniskens, GJ ;
Pieffers, M ;
Versteeg, EMM ;
Petitou, M ;
Veerkamp, JH ;
van Kuppevelt, TH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10982-10986
[7]
Order out of chaos: Assembly of ligand binding sites in heparan sulfate [J].
Esko, JD ;
Selleck, SB .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :435-471
[8]
Molecular diversity of heparan sulfate [J].
Esko, JD ;
Lindahl, U .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :169-173
[9]
Age-dependent modulation of heparan sulfate structure and function [J].
Feyzi, E ;
Saldeen, T ;
Larsson, E ;
Lindahl, U ;
Salmivirta, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13395-13398
[10]
Glypicans: proteoglycans with a surprise [J].
Filmus, J ;
Selleck, SB .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (04) :497-501